                         SEQUENCE LISTING

<110>  BioNTech RNA Pharmaceuticals GmbH
 
<120>  METHODS FOR PREDICTING THE USEFULNESS OF DISEASE SPECIFIC AMINO 
       ACID MODIFICATIONS FOR IMMUNOTHERAPY

<130>  674-187 PCT2

<150>  PCT/EP2017/064140
<151>  2017-06-09

<160>  23    

<170>  PatentIn version 3.5

<210>  1
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Linker sequence


<220>
<221>  REPEAT
<222>  (1)..(3)
<223>  Portion of sequence repeated a times, wherein a is independently 
       a number selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 
       13, 14, 15, 16, 17, 18, 19, or 20

<220>
<221>  MISC_FEATURE
<222>  (1)..(15)
<223>  a + b + c + d + e are different from 0 and preferably are 2 or 
       more, 3 or more, 4 or more or 5 or more

<220>
<221>  REPEAT
<222>  (4)..(6)
<223>  Portion of sequence repeated b times, wherein b is independently 
       a number selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 
       13, 14, 15, 16, 17, 18, 19, or 20

<220>
<221>  REPEAT
<222>  (7)..(9)
<223>  Portion of sequence repeated c times, wherein c is independently 
       a number selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 
       13, 14, 15, 16, 17, 18, 19, or 20

<220>
<221>  REPEAT
<222>  (10)..(12)
<223>  Portion of sequence repeated d times, wherein d is independently 
       a number selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 
       13, 14, 15, 16, 17, 18, 19, or 20

<220>
<221>  REPEAT
<222>  (13)..(15)
<223>  Portion of sequence repeated e times, wherein e is independently 
       a number selected from 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 
       13, 14, 15, 16, 17, 18, 19, or 20

<400>  1

Gly Gly Ser Gly Ser Ser Gly Gly Gly Ser Ser Gly Gly Ser Gly 
1               5                   10                  15  


<210>  2
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Linker sequence

<400>  2

Gly Gly Ser Gly Gly Gly Gly Ser Gly 
1               5                   


<210>  3
<211>  9
<212>  PRT
<213>  Homo sapiens

<400>  3

Lys Ser Gln Arg Glu Phe Val Arg Arg 
1               5                   


<210>  4
<211>  9
<212>  PRT
<213>  Homo sapiens

<400>  4

Met Arg Met Asn Gln Gly Val Cys Cys 
1               5                   


<210>  5
<211>  14
<212>  PRT
<213>  Homo sapiens

<400>  5

Lys Phe Gly Gln Gly Leu Glu Asp Gln Leu Ala Thr Lys Ser 
1               5                   10                  


<210>  6
<211>  15
<212>  PRT
<213>  Homo sapiens

<400>  6

Gly Gln Gly Leu Glu Asp Gln Leu Ala Gln Thr Lys Ser Leu Ser 
1               5                   10                  15  


<210>  7
<211>  15
<212>  PRT
<213>  Homo sapiens

<400>  7

Gly Leu Glu Asp Gln Leu Ala Gln Thr Lys Ser Leu Ser Leu Asp 
1               5                   10                  15  


<210>  8
<211>  15
<212>  PRT
<213>  Homo sapiens

<400>  8

Glu Asp Gln Leu Ala Gln Thr Lys Ser Leu Ser Leu Asp Asp Cys 
1               5                   10                  15  


<210>  9
<211>  15
<212>  PRT
<213>  Homo sapiens

<400>  9

Thr Arg Leu Ser Lys Val Phe Ser Ala Met Leu Ala Ile Tyr Ser 
1               5                   10                  15  


<210>  10
<211>  15
<212>  PRT
<213>  Homo sapiens

<400>  10

Lys Val Phe Ser Ala Met Leu Ala Ile Tyr Ser Asn Lys Pro Ala 
1               5                   10                  15  


<210>  11
<211>  15
<212>  PRT
<213>  Homo sapiens

<400>  11

Ala Met Leu Ala Ile Tyr Ser Asn Lys Pro Ala Leu Trp Ile Met 
1               5                   10                  15  


<210>  12
<211>  15
<212>  PRT
<213>  Homo sapiens

<400>  12

Ile Tyr Ser Asn Lys Pro Ala Leu Trp Ile Met Ala Ala Lys Trp 
1               5                   10                  15  


<210>  13
<211>  19
<212>  PRT
<213>  Homo sapiens

<400>  13

Ala Asp His Asp Leu Gly Arg Leu His Ser Cys Val Met Ala Ser Leu 
1               5                   10                  15      


Arg Ala Gln 
            


<210>  14
<211>  9
<212>  PRT
<213>  Homo sapiens

<400>  14

His Asp Leu Gly Arg Leu His Ser Cys 
1               5                   


<210>  15
<211>  9
<212>  PRT
<213>  Homo sapiens

<400>  15

His Ser Cys Val Met Ala Ser Leu Arg 
1               5                   


<210>  16
<211>  15
<212>  PRT
<213>  Homo sapiens

<400>  16

Ala Cys Tyr Gly Ala Asp His Asp Leu Gly Arg Leu His Ser Cys 
1               5                   10                  15  


<210>  17
<211>  15
<212>  PRT
<213>  Homo sapiens

<400>  17

Ala Asp His Asp Leu Gly Arg Leu His Ser Cys Val Met Ala Ser 
1               5                   10                  15  


<210>  18
<211>  15
<212>  PRT
<213>  Homo sapiens

<400>  18

Leu Gly Arg Leu His Ser Cys Val Met Ala Ser Leu Arg Ala Gln 
1               5                   10                  15  


<210>  19
<211>  15
<212>  PRT
<213>  Homo sapiens

<400>  19

His Ser Cys Val Met Ala Ser Leu Arg Ala Gln Ser Pro Ile Pro 
1               5                   10                  15  


<210>  20
<211>  31
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Oligonucleotide

<400>  20
gccaccatga tcctaaacaa agctctgmtg c                                      31


<210>  21
<211>  33
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Oligonucleotide

<400>  21
tatgcgatcg ctcacaakgg cccytggtgt ctg                                    33


<210>  22
<211>  27
<212>  PRT
<213>  Homo sapiens

<400>  22

Cys Ser Pro Gly Phe Phe Lys Phe Glu Ala Ser Glu Ser Leu Cys Leu 
1               5                   10                  15      


Glu Cys Pro Glu His Thr Leu Pro Ser Pro Glu 
            20                  25          


<210>  23
<211>  18
<212>  PRT
<213>  Homo sapiens

<400>  23

Met Pro Arg Ser Glu Ser Tyr Cys Phe Pro Gly Val Thr Leu Ala Ser 
1               5                   10                  15      


Thr Pro 
        


